Diagnostic Accuracy of Rubidium-82 Myocardial Perfusion Imaging With Hybrid Positron Emission Tomography/Computed Tomography in the Detection of Coronary Artery Disease  by Sampson, Uchechukwu K. et al.
E
(
a
c
(
o
t
m
a
s
s
t
F
o
a
a
Journal of the American College of Cardiology Vol. 49, No. 10, 2007
© 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00
PCardiac Imaging
Diagnostic Accuracy of Rubidium-82
Myocardial Perfusion Imaging With Hybrid
Positron Emission Tomography/Computed
Tomography in the Detection of Coronary Artery Disease
Uchechukwu K. Sampson, MD, MPH, MBA, MSC(OXON),* Sharmila Dorbala, MD, FACC,*†
Atul Limaye, MD, MRCP,* Raymond Kwong, MD,*† Marcelo F. Di Carli, MD, FACC, FAHA*†
Boston, Massachusetts
Objectives Our objective was to determine the accuracy of rubidium-82 myocardial perfusion positron emission
tomography-computed tomography (PET-CT) imaging for detecting obstructive coronary artery disease (CAD).
Background Hybrid PET-CT is a new noninvasive imaging modality for evaluating patients with known or suspected CAD.
Methods We evaluated 64 consecutive patients with suspected CAD undergoing rest-stress rubidium-82 cardiac PET-CT
(CT was only used for attenuation correction) and coronary angiography within 7 days (range 1 to 180 days).
Patients with known CAD, previous myocardial infarction, or revascularization were excluded. Thirty-eight pa-
tients with a low likelihood for CAD were also studied. Obstructive CAD was defined as 70% diameter stenosis
on angiography.
Results The mean age of the patients was 62  15 years, with a body mass index of 31  8 kg/m2. Chest pain and/or
dyspnea were the predominant reasons for evaluation. Stress perfusion defects were detected in 41 of 44 pa-
tients with obstructive CAD (sensitivity 93%, 95% confidence interval [CI] 87 to 99). The specificity of PET-CT was
83% (48 of 58, 95% CI 71 to 91), and its overall diagnostic accuracy was 87% (95% CI 79 to 93). All patients
with a low likelihood for CAD showed normal scans, for a normalcy rate of 100% (38 of 38, 95% CI 91 to 100).
The sensitivity for detecting CAD in patients with single and multivessel (2 vessels) disease was 92% (22 of
24, 95% CI 74 to 99) and 95% (19 of 20, 95% CI 74 to 99), respectively.
Conclusions Myocardial perfusion PET-CT affords high sensitivity and overall accuracy for detecting CAD, including patients
with single-vessel disease, women, and obese patients. (J Am Coll Cardiol 2007;49:1052–8) © 2007 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.12.015o
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iarly detection and treatment of coronary artery disease
CAD) remains paramount given its morbidity, mortality,
nd economic consequences. Over the last 2.5 decades,
ardiac single-photon emission computed tomography
SPECT) has played a dominant role in the detection of
bstructive CAD, risk stratification, and prediction of
herapeutic benefit (1–4). Cardiac positron emission to-
ography (PET) imaging using rubidium-82 or N-13
mmonia is emerging as a potential alternative to SPECT in
elected patients (e.g., obese patients), owing to its higher
patial resolution, accurate attenuation correction, quantita-
ive capabilities, and improved availability (5–12).
rom the *Divisions of Nuclear Medicine and Cardiovascular Imaging, Department
f Radiology, and the †Division of Cardiology, Department of Medicine, Brigham
nd Women’s Hospital, Harvard Medical School, Boston, Massachusetts.u
Manuscript received April 26, 2006; revised manuscript received August 21, 2006,
ccepted August 28, 2006.Over the past few years, we have witnessed a rapid evolution
f PET instrumentation, which now offers higher sensitivity
nd hybrid scanners integrating PET and computed tomogra-
hy (CT). Hybrid PET-CT scanners account for approxi-
ately 80% of the new PET units installed (13). Although
T-based attenuation correction for PET has been widely
dopted in oncology, it presents challenges in cardiac imaging.
ifferences in spatial resolution and breathing patterns be-
ween CT and PET may occasionally lead to misregistration of
maging data, resulting in incorrect attenuation correction and
nsuing artifacts that may impact diagnostic accuracy. Accord-
ngly, we sought to determine the diagnostic accuracy of
ubidium-82 myocardial perfusion imaging for detecting ob-
tructive CAD in subjects referred for diagnosis of chest pain
r nonclassic symptoms with multiple risk factors using an
ntegrated PET-CT system, whereas the CT scan was only
sed for purposes of attenuation correction.
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atient population. Our study sample was derived from a
onsecutive diagnostic cohort of patients with suspected
AD because of chest pain or nonclassic symptoms with
ultiple risk factors referred for cardiac PET-CT imaging
rom November 2003 to January 2005. We included pa-
ients who underwent coronary angiography within 6
onths of their incident PET-CT study. Patients with a
istory of CAD (CAD on coronary angiography), myocar-
ial infarction (MI) and/or evidence of pathologic Q waves
n resting electrocardiogram, or prior revascularization were
xcluded. In addition, we included a group of patients with
low likelihood for CAD (5% pretest likelihood) defined
y the absence of symptoms; coronary risk factors including
iabetes, hypertension, dyslipidemia, or smoking; and a
ormal resting electrocardiogram (14).
ET. All patients were studied using a whole-body
ET-CT scanner (Discovery ST Lightspeed 16, GE
ealthcare, Milwaukee, Wisconsin). Patients were studied
fter an overnight fast and 24-h cessation of all caffeine-
ontaining or methylxanthine-containing substances. After
scout CT acquisition (120 kVp, 10 mA) used for proper
atient positioning, a CT transmission scan (140 kVp, 20 to
0 mA, pitch 1.35) was acquired. The patients were then
njected with 40 to 60 mCi of rubidium-82 at rest, and after
90- to 120-s delay (to allow for adequate blood pool
learance), gated emission images were obtained for 5 min.
mmediately after rest imaging, patients underwent phar-
acologic stress testing using standard infusions of dipyrid-
mole (0.14 mg/kg/min for 4 min, n 40), adenosine (0.14
g/kg/min for 6 min, n  20), or dobutamine (10 g/kg/
in increments to a maximum of 40 g/kg/min or until
chieving 85% of maximum predictive heart rate, n 4). At
eak stress, a second dose of 40 to 60 mCi of rubidium-82
as administered and emission images were acquired as
reviously described. On completion of the stress images, a
ost-emission CT transmission scan (140 kVp, 20 to 30
A, pitch 1.35) was repeated and used for attenuation
orrection of the stress images. The second CT transmission
can is important because during pharmacologic stress
especially vasodilator stress), the heart changes its size and
osition within the chest (because of the different breathing
attern during pharmacologic stress). The gated PET im-
ges were reconstructed using an ordered subset expectation
aximization algorithm (2 iterations, 30 subsets), and then
ere summed for review. The effective radiation dosimetry
rom this study was 13.8 mSv (12 mSv from the rest-stress
ubidium-82 injections, 1.4 mSv from the 2 CT transmis-
ion scans, and 0.4 from the 2 scout scans).
ata analyses. Two experienced nuclear cardiologists
S.D., M.D.C.) reviewed each rest-stress myocardial perfu-
ion PET study blinded to the results of the coronary
ngiograms. A 17-segment, 5-point (0  normal uptake, 4
absent uptake) scoring system was used to compute a
ummed stress score, a summed rest score, and a summed difference score. Regional perfu-
ion abnormalities were assigned
o a coronary arterial territory
ased on a generally accepted
tandard (15).
oronary angiography. All pa-
ients underwent coronary an-
iography using a standard tech-
ique within 6 months of the
ndex PET-CT study. Cinean-
iograms of the coronary arteries
ere obtained in multiple projec-
ions using a Phillips Integris
H3000 angiographic system (9-
nch [22/17/13 cm] triple-mode
igh-contrast image intensifier)
Philips Medical Systems, Rotterdam, the Netherlands).
he angiographic criterion used to define the presence of
ignificant CAD was a visually determined diameter steno-
is of 70% for the left anterior descending, left circumflex,
nd right coronary arteries or their major branches, and
50% for the left main coronary segment.
tatistical analysis. Continuous data are presented as
ean  SD, whereas categorical and ordinal data are
resented as counts and simple proportions. We used a
inary classification for the presence or absence of CAD
sing angiographic results as the reference standard. By
eans of a 2 2 table, sensitivity, specificity, and diagnostic
ccuracy rates were derived according to the standard
efinitions and were represented with 95% confidence
ntervals (CIs). The CIs were computed according to the
ilson method (16). Because of the small number of
atients with angiographically normal coronary arteries, the
alculated specificity in this analysis included the low-
ikelihood patients and those with angiographically normal
oronary arteries. The possibility of verification bias (17,18)
ecessitated the derivation of a normalcy rate—a surrogate
or true specificity from a group of 38 patients with a low
ikelihood for CAD but without coronary angiography.
nterobserver variability was assessed in 20 additional pa-
ients (10 normal and 10 abnormal) using the kappa
tatistic.
esults
he study consisted of 102 consecutive patients (mean age
2 years, 61% male), of whom 64 patients compose our
iagnostic group and 38 patients our low likelihood group
Table 1). The mean body mass index (BMI) was 30.8
g/m2, and the majority of patients (78%) were overweight
r obese (BMI 25 kg/m2). Coronary risk factors were
revalent, especially hypertension, dyslipidemia, and diabe-
es. The median time interval between the stress
ubidium-82 PET-CT and coronary angiography was 7
Abbreviations
and Acronyms
BMI  body mass index
CAD  coronary artery
disease
CI  confidence interval
CT  computed
tomography
MI  myocardial infarction
PET  positron emission
tomography
SPECT  single-photon
emission computed
tomographyays (range 1 to 180 days).
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ngiography. OVERALL DETECTION OF CAD. Stress PET
orrectly identified 41 of the 44 patients with evidence of
70% stenosis on coronary angiography (sensitivity 93%,
5% CI 87% to 99%) (Table 2). In patients with single-
essel disease and multivessel (2-vessel) disease,
ubidium-82 PET-CT had a sensitivity of 92% (22 of 24
atients, 95% CI 74% to 99%), and 95% (19 of 20 patients,
5% CI 74% to 99%), respectively (Table 3). The overall
ensitivity in this diagnostic population was equally high in
en (90%, 27 of 30, 95% CI 73% to 98%) and women
100%, 14 of 14, 95% CI 77% to 100%). Likewise, stress
ubidium-82 PET was also equally sensitive to detect
bstructive CAD in obese (BMI 30 kg/m2), (100%, 32 of
2 patients, 95% CI 84% to 100%), and nonobese individ-
als (87%, 32 of 32 patients, 95% CI 66% to 97%). Figures
and 2 are representative examples of normal and abnormal
ubidium-82 myocardial perfusion PET-CT scans in obese
omen and men.
Stress PET correctly identified the absence of disease in
0 of 20 patients without significant angiographic CAD,
nd in all 38 low-likelihood patients (normalcy rate 100%,
5% CI 91% to 100%) (specificity 83%, 48 of 58 patients,
5% CI 71% to 91%).
SSESSMENT OF ANATOMICAL CAD EXTENT. The exact
greement between stress rubidium-82 PET-CT and cor-
nary angiography in assessing the anatomical extent of
AD (i.e., correctly identifying single-vessel or multivessel
haracteristics of Patients With Suspected CAD
Table 1 Characteristics of Patients With Suspected CAD
n 64
Age (yrs) 62  14.9 (range 19–87)
Body mass index (kg/m2) 31  8 (range 17–54)
Male gender 39 (61%)
Hypertension 55 (86%)
Dyslipidemia 34 (53%)
Diabetes 23 (36%)
Family history of CAD 20 (31%)
Cigarette smoking 16 (25%)
Endstage renal disease 3 (5%)
Peripheral vascular disease 5 (8%)
Chest pain 29 (45%)
Dyspnea 28 (44%)
alues expressed as n (%) or mean  SD.
CAD  coronary artery disease.
etection of CAD by Cardiac PET-CT in4 Pa e ts Who Underwent Coronary Angiography
Table 2 Detection of CAD by Cardiac PET-CT in64 Patients Who Underwent Coronary Angiography
CAD by Angiography
TotalNo Yes
CAD by PET-CT
No 10 3 13
Yes 10 41 51
Total 20 44 64mAD  coronary artery disease; PET-CT  position emission tomography-computed tomography.AD [i.e., 2-vessel CAD]) was 64% (28 of 44) (Table 3).
f the 20 patients with multivessel disease by angiography,
nly 58% (11 of 20, 95% CI 32% to 77%) had concordant
xtent of disease on stress PET. Of the 9 discordant cases,
had no perfusion abnormalities on stress PET and the
emainder had perfusion defects in only 1 vascular territory.
f the 24 patients with single-vessel disease by angiogra-
hy, 68% (17 of 24, 95% CI 49% to 87%) had concordant
xtent of disease on stress PET; 5 of 7 discordant cases had
tress perfusion defects extending into 2 vascular territories
nd 2 had normal myocardial perfusion.
BSERVER AGREEMENT. Interobserver variability was de-
ermined in a separate subgroup of 20 patients. Both readers
oncordantly grouped 19 of 20 scans as normal or abnormal.
nterobserver agreement for scan interpretation was found
o be excellent (  0.95) with regard to the overall
iagnosis of CAD.
iscussion
e have evaluated the diagnostic performance of integrated
ubidium-82 myocardial perfusion PET-CT imaging, in
hich the CT scan was used only for attenuation correction
f the perfusion images, in the detection of obstructive
therosclerosis among patients with suspected CAD. The
verall sensitivity for diagnosing obstructive CAD was 93%
n overweight and obese individuals (mean BMI 30
g/m2), and it was equally high in men and women. Unlike
revious reports on the diagnostic accuracy of PET (19,20),
ur study cohort was composed of only patients with
uspected CAD. We excluded patients with prior MI, prior
evascularization, or known CAD, whereas previous reports
ncluded patients with previous MI (range 13% to 75% of
atients in those reports). Thus, our findings suggest an
mprovement in diagnostic accuracy with current PET-CT
echnology.
The diagnostic sensitivity of rubidium-82 myocardial
erfusion PET-CT in patients with single-vessel disease
92%) was higher than that reported with conventional
echniques (21). Further, the diagnostic sensitivity was
qually high in obese and nonobese individuals (mean BMI
30 kg/m2). The effective radiation dose from rubidium-82
xtent of CAD by Cardiac PET-CT in the4 Pa ients With Signifi ant Angiographic CAD
Table 3 Extent of CAD by Cardiac PET-CT in the44 Patients With Significant Angiographic CAD
Number of Diseased Vessels
by Angiography
Total1 >2
Number of diseased vascular
territories by PET-CT
0 2 1 3
1 17 8 25
2 5 11 16
Total 24 20 44
bbreviations as in Table 2.yocardial perfusion PET-CT is comparable to that of
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22), and significantly lower than dual-isotope (201thallium/
9mTc) SPECT (22). The overall sensitivity, specificity, and
iagnostic accuracy of rubidium-82 myocardial perfusion
ET-CT in the current study are comparable with that of
T coronary angiography, and higher than that reported
ith either stress SPECT or stress echocardiography (21).
hese results have important implications in light of the
pidemic of obesity in the U.S., which now poses increased
hallenges to noninvasive diagnostic imaging (23,24).
Although stress PET had excellent diagnostic sensitivity for
etecting patients with single or multivessel disease, its ability
o delineate the anatomical extent of disease was somewhat
imited. Only 11 of 20 patients (55%) with angiographic
ultivessel disease had concordant extent of disease on stress
Figure 1 Normal Rubidium-82 Myocardial Perfusion PET-CT Stu
Dipyridamole-stress and rest rubidium-82 positron emission tomography-computed
dle), and horizontal long-axis (bottom) slices in a 55-year-old woman with atypical
represent progression from the apical (left) to the basal (right) part of the heart,
rior wall at the bottom, and the interventricular septum to the left. The vertical lon
and are oriented with the anterior wall on top, inferior wall at the bottom, and the
sion from the inferior (left) to the anterior (right) walls, and are oriented with the
show normal myocardial perfusion throughout the LV and represent a normal scanET, whereas the remainder of patients had stress defects in vnly 1 vascular territory. This suggests that as with SPECT,
onquantitative PET often uncovers only the territory supplied
y the most severe stenosis. This is based on the fact that in
atients with CAD, coronary vasodilator reserve is often
bnormal, even in territories supplied by noncritical angio-
raphic stenoses (25,26), thereby reducing the heterogeneity of
ow between normal and abnormal zones and limiting the
bility to delineate the presence of multivessel CAD. There is
rowing evidence showing that absolute quantification of
oronary vasodilator reserve by PET can potentially overcome
his limitation (26,27). However, quantitative measures of
yocardial blood flow are not widely used clinically and were
ot performed in this study.
Of the 24 patients with angiographic single-vessel dis-
ase, 5 patients had perfusion defects in more than 1
raphy (PET-CT) images in corresponding short-axis (top), vertical long-axis (mid-
pain (height 5’5”, weight 205 lbs, body mass index  34). The short-axis slices
e oriented with the anterior wall on the top, the lateral wall to the right, the infe-
slices represent progression from the septum (left) to the lateral (right) walls,
ntricular (LV) apex to the right. The horizontal long-axis slices represent progres-
wall on the left, lateral wall to the right, and the LV apex on the top. The imagesdy
tomog
chest
and ar
g-axis
left ve
septal
.ascular territory—a finding consistent with the notion of
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ular) in remote myocardium subtended by nondiseased
essels or noncritical coronary stenoses (i.e., 70%). This
ikely reflects the fact that patients with coronary risk
actors, such as those in this study, show abnormal coronary
asodilator function that may manifest as a perfusion
bnormality even in the absence of severe luminal narrowing
n the epicardial coronary arteries (28).
In our calculation of specificity, we combined the PET
esults in the patients with no significant disease on angiog-
aphy (i.e., 70%) and those in the group with a low
ikelihood of CAD because of the small number of patients
ithout critical disease on angiography (17,18). The spec-
ficity of PET-CT in this study (83%) was comparable with
hat reported in previous studies using dedicated PET
echnology (86%) (19,20). The calculated specificity may be
ffected by several factors. First, most of our patients
95%) with normal stress PET-CT results are not referred
Figure 2 Abnormal Rubidium-82 Myocardial Perfusion PET-CT S
Dipyridamole-stress and rest rubidium-82 PET-CT images in corresponding short-ax
62-year-old man with atypical chest pain (height 6’0”, weight 235 lbs, body mass
tent with a moderately large area of severe ischemia in the lateral and inferolatera
LV segments and the apex (distal left anterior descending territory). Abbreviationsor coronary angiography, thereby introducing a potential cias in the assessment of the true negative fraction (29). As
n other studies, we also derived a normalcy rate as a proxy
or true specificity based on a group of low-likelihood
atients. The normalcy rate, reflecting the proportion of
atients with a low likelihood for CAD with normal stress
ET-CT study results, was 100%. This normalcy rate is
onsistent with preliminary results from our laboratory
orrelating myocardial perfusion PET with the results of
T coronary angiography using either 16- or 64-slice
ultidetector computed tomography scanners. Among 43
atients with angiographically normal coronary arteries
ased on CT coronary angiography, 39 had normal stress
ET (91%) (30). Second, the calculation of specificity
efines an artificial classification of anatomical CAD into a
inary outcome (i.e., present or absent) rather than as a
ontinuum spectrum of severity. It is possible that some
atients with multiple risk factors may have shown true
erfusion abnormalities reflecting vascular dysfunction that
), vertical long-axis (middle), and horizontal long-axis (bottom) slices in a
 31.9). The orientation is as in Figure 1. The images are abnormal and consis-
(left circumflex territory), and a small area of mild ischemia involving the apical
Figure 1.tudy
is (top
index
l walls
as inan be underestimated by conventional measures of stenosis
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ositive PET-CT studies. Indeed, studies of CAD regres-
ion show that improvements in endothelial function after
tatin therapy can lead to significant improvements in
egional perfusion even in the absence of a change in the
umen diameter of a coronary stenosis (31). Despite our best
fforts to exclude artifacts, however, it is also conceivable
hat potential misalignment between the CT transmission
nd emission data may have resulted in errors in attenuation
orrection, leading to artifacts and falsely positive studies.
tudy limitations. This study has a relatively small sample
ize, and further confirmation of our results is necessary in
arger patient groups. Future studies should also include
uantitative measures of myocardial perfusion to test
hether this approach can help improve the assessment of
he anatomical extent of CAD. The severity of angiographic
tenoses was assessed by expert visual analysis rather than by
uantitative techniques. However, this analysis reflects cur-
ent clinical practice and the way in which decisions
egarding coronary revascularization are performed. As with
ther noninvasive modalities (21), the reported sensitivity
nd specificity estimates in this study may be distorted
y referral bias. This is a common limitation of an
ngiography-based approach for defining the diagnostic
ccuracy of noninvasive testing (shared by all clinical mo-
alities), in which the referral to cardiac catheterization is
nfluenced by the amount of ischemia present on the study.
onclusions
yocardial perfusion PET-CT provides high sensitivity for
he detection of CAD. The high diagnostic accuracy is
pplicable to both men and women, nonobese and obese
atients, and to those with single-vessel as well as multives-
el coronary disease. Rest and stress imaging is completed in
pproximately 25 min. Despite its high overall sensitivity,
ardiac PET-CT may underestimate the anatomical extent
f CAD in some patients with multivessel disease.
eprint requests and correspondence: Dr. Marcelo F. Di Carli,
ivision of Nuclear Medicine/PET, Department of Radiology,
righam and Women’s Hospital, 75 Francis Street, Boston,
assachusetts 02115. E-mail: mdicarli@partners.org.
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